speaker, years ago the nhs spent five hundred million pounds on tamiflu without seeing the day on the effectiveness or safety and rather than being an isolated case it is normal for the drug industry to have almost complete control over the evidence based upon which crucial public decisions are made. will the prime minister asked to make available the full chemical study reports on tamiflu so the doctors, patients and taxpayers are not misled? >> my hon. friend does excellent work on behalf of the taxpayer through all of the very good questions and work that he does. he raises an important issue not only because of the cost to the taxpayer but also because of possible overstatement of benefits to patients. there does need to be more transparency in the clinical trials data. we are committed to make sure that happened in the european medicine agency's work is supported on this and from next year there will be a legal requirement to publish summary reports from clinical trials. >> lindsay white. >> this week we learned despite assurances that ridge taking place that the agency made mini